Effects of psychoactive drugs in the Vogel conflict test in mice

Japanese Journal of Pharmacology

Volumn 80, Issue 2, 1999, Pages 111-118

  Umezu, Toyoshi ^a  

^a NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

Author keywords

Anxiety; Psychoactive drug; Vogel conflict test (mouse)

Indexed keywords

ANXIOLYTIC AGENT; BACLOFEN; BUSPIRONE; CAFFEINE; CHLORPROMAZINE; CIMETIDINE; CYCLAZOCINE; DIAZEPAM; DIZOCILPINE; HALOPERIDOL; PENTOBARBITAL; PSYCHOTROPIC AGENT; SCOPOLAMINE; YOHIMBINE;

ANIMAL EXPERIMENT; ARTICLE; CONFLICT; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG SCREENING; ELECTRIC SHOCK; MALE; MOUSE; NONHUMAN; PSYCHOPHARMACOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032814240     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.80.111     Document Type: Article

References (43)

1. Vogel JR, Beer B and Clody DE: A simple and reliable conflict procedure for testing antianxiety agents. Psychopharmacologia (Berl) 21, 1-7 (1971)
2. Umezu T: Assessment of anxiolytics (5) - Vogel-type conflict task in mice. Jpn J Psychopharmacol 15, 305-314 (1995) (Abstr in English)
3. Umezu T, Yonemoto J, Soma Y and Miura T: Behavioral effects of trichloroethylene and tetrachloroethylene in mice. Pharmacol Biochem Behav 58, 665-671 (1997)
4. Commissaris RL: Conflict behaviors as animal models for the study of anxiety. In Methods in Behavioral Pharmacology, Edited by Haaren FV, pp 443-474, Elsevier Science Publishing, Amsterdam (1993)
5. 2-Adrenoceptor antagonist activity may account for the effects of buspirone in an anti-conflict test in the rat. Eur J Pharmacol 155, 129-137 (1988)
6. Venault P, Jacquot F, Save E, Sara S and Chapouthier G: Anxiogenic-like effects of yohimbine and idazoxan in two behavioral situation in mice. Life Sci 52, 639-645 (1993)
7. Kuribara H, Furusawa K and Tadokoro S: Effects of ethanol, caffeine and nicotine on conflict behavior established under an operant situation in mice. Jpn J Alcohol Drug Depend 22, 101-109 (1987)
8. Kuribara H, Haraguchi H and Tadokoro S: Anticonflict effect of caffeine: investigation by punishment and hypertonic NaCl solution procedure in mice. Jpn J Alcohol Drug Depend 24, 144-153 (1989)
9. Haraguchi H and Kuribara H: Behavioral effects of adenosine agonists: Evaluation by punishment, discrete shuttle avoidance and activity tests in mice. Jpn J Pharmacol 55, 303-310 (1991)
10. Kuribara H and Tadokoro S: Time-related facilitation and suppression of drinking by muscarinic anticholinergic drugs in water non-deprived rats. Jpn J Pharmacol 48, 205-211 (1988)
11. Kameyama T, Kamei H and Nabeshima T: A role played sigma receptors in the conditioned suppression of motility in mice. Psychopharmacology (Berl) 94, 515-520 (1988)
12. Corbett R and Dunn RW: Effects of 5,7-dichlorokynurenic acid on conflict, social interaction and plus maze behaviors. Neuropharmacology 32, 461-466 (1993)
13. Kuribara H, Fujiwara S, Yasuda H and Tadokoro S: The anti-conflict effect of MK-801, an NMDA antagonist: Investigation by punishment procedure in mice. Jpn J Pharmacol 54, 250-252 (1990)
14. Pich EM and Samanin R: Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats: Possible role of dopamine. Psychopharmacology (Berl) 89, 125-130 (1986)
15. 1A receptor agonists 8-HO-DPAT, ipsapirone and buspirone in the rat. Eur J Pharmacol 249, 341-351 (1993)
16. Seidel WF, Cohen SA, Bliwise NG and Dement WC: Buspirone: An anxiolytic without sedative effect. Psychopharmacology (Berl) 87, 371-373 (1985)
17. Stefanski R, Palejko W, Kostowski W and Plaznik A: The comparison of benzodiazepine derivatives and serotonergic agonists and antagonists in two animal models of anxiety. Neuropharmacology 31, 1251-1258 (1992)
18. 1A receptor agonists. Neuropharmacology 32, 977-985 (1993)
19. 1A agonist buspirone and benzodiazepine anxiolytic diazepam on conflict behaviors in mice. Kitakanto Igaku 43, 289-293 (1993) (Abstr in English)
20. 1A agonist, on conflict behavior and ambulatory activity in mice: Comparison with those of buspirone, tandospirone and diazepam. Jpn J Pharmacol 64, 273-280 (1994)
21. Garrett KM, Niekrasz I, Haque D, Parker KM and Scale TW: Genotypic differences between C57BL/6 and A inbred mice in anxiolytic and sedative actions of diazepam. Behav Genet 28, 125-136 (1998)
22. Kudo Y and Kudo T: Recent progress in development of psychotropic drugs (1)-anti-anxiety drugs. Jpn J Psychopharmacol 15, 75-86 (1995)
23. Wiley JL, Compton AD and Porter JH: Effects of four anti-psychotic on punished responding in rats. Pharmacol Biochem Behav 45, 263-267 (1993)
24. Helton DR, Tizzano JP, Monn JA, Schoepp DD and Kallman MJ: Anxiolytic and side-effect profile of LY354740: A potent, highly selective, orally active agonist for group II metabotropic glutamate receptors. J Pharmacol Exp Ther 284, 651-660 (1998)
25. Lister RG: The use of a plus-maze to measure anxiety in the mice. Psychopharmacology (Berl) 92, 180-185 (1987)
26. Bhattacharya SK and Mitra SK: Anxiogenic activity of quinine-an experimental study in rodents. Indian J Exp Biol 30, 33-37 (1992)
27. Jain N, Kemp N, Adeyemo O, Buchanan P and Stone TW: Anxiolytic activity of adenosine receptor activation in mice. Br J Pharmacol 116, 2127-2133 (1995)
28. Lapin IP: Anxiogenic effect of phenylethylamine and amphetamine in the elevated plus-maze in mice and its attenuation by ethanol. Pharmacol Biochem Behav 44, 241-243 (1993)
29. Lapin IP and Politi V: Anxiolytic effect of indol-3-pyruvic acid (IPA) in mice. Pharmacol Res 28, 129-134 (1993)
30. Dalvi A and Rodgers RJ: GABAergic influences on plus-maze behavior in mice. Psychopharmacology (Berl) 128, 380-397 (1996)
31. Cao BJ and Rodgers RJ: Comparative behavioral profiles of buspirone and its metabolite 1-(2-pyrimidinyl)-piporazine (1-PPP) in the murine elevated plus-maze. Neuropharmacology 36, 1089-1097 (1997)
32. Cole JC and Rodgers RJ: Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol. Psychopharmacology (Berl) 114, 288-296 (1994)
33. Hascoet M and Bourin M: A new approach to the light/dark test procedure in mice. Pharmacol Biochem Behav 60, 645-653 (1998)
34. 2 receptor subtype antagonists in rat and mouse model of anxiety. Neuropharmacology 36, 793-802 (1997)
35. Griebel G, Sanger DJ and Perrault G: Further evidence for differences between non-selective and BZ-1 (omega 1) selective, benzodiazepine receptor ligands in murine models "state" and "trait" anxiety. Neuropharmacology 35, 1081-1091 (1996)
36. Shimada T, Matsumoto K, Osanai M, Matsuda H, Terasawa K and Watanabe H: The modified light/dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenic drugs. Gen Pharmacol 26, 205-210 (1995)
37. Imaizumi M, Suzuki T, Machida H and Onodera K: A fully automated apparatus for a light/dark test measuring anxiolytic or anxiogenic effects of drugs in mice. Jpn J Psychopharmacol 14, 83-91 (1994)
38. Lapine IP: Antagonism of kynurenic acid to anxiogens in mice. Life Sci 63, 231-236 (1998)
39. Imaizumi M, Miyazaki S and Onodera K: Effects of xanthine derivatives in a light/dark test in mice and the contribution of adenosine receptors. Methods Find Exp Clin Pharmacol 16, 639-644 (1994)
40. Griebel G, Perrault G and Sanger DJ: Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone. Psychopharmacology (Berl) 138, 55-66 (1998)
41. Onaiv ES and Martin BR: Neuropharmacological and physiological validation of a computer-controlled two-compartment black and white box for the assessment of anxiety. Prog Neuropsychopharmacol Biol Psychiatry 13, 963-976 (1989)
42. Costall B and Naylor RJ: Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor. Br J Pharmacol 116, 2989-2999 (1995)
43. Young R and Johnson DN: A fully automated light/dark apparatus useful for comparing anxiolytic agents. Pharmacol Biochem Behav 40, 739-743 (1991)